CMMC vs FDA 21 CFR Part 11
CMMC
DoD certification model verifying cybersecurity for FCI and CUI
FDA 21 CFR Part 11
FDA regulation for trustworthy electronic records and signatures
Quick Verdict
CMMC mandates cybersecurity certification for DoD contractors protecting FCI/CUI, while FDA 21 CFR Part 11 regulates electronic records/signatures for life sciences ensuring data integrity. Defense firms adopt CMMC for contracts; pharma uses Part 11 for compliance and inspections.
CMMC
Cybersecurity Maturity Model Certification (CMMC) 2.0
Key Features
- Three cumulative certification levels aligning FAR and NIST controls
- Independent C3PAO and DIBCAC assessments for verification
- 110 NIST SP 800-171 practices protecting CUI across 14 domains
- Mandatory flow-down requirements to supply chain subcontractors
- Limited POA&Ms with 180-day closure and SPRS reporting
FDA 21 CFR Part 11
21 CFR Part 11 Electronic Records; Electronic Signatures
Key Features
- Secure, computer-generated time-stamped audit trails
- Validation for system accuracy and reliability
- Access limitation to authorized individuals only
- Electronic signatures with non-repudiation controls
- Additional encryption for open systems
Detailed Analysis
A comprehensive look at the specific requirements, scope, and impact of each standard.
CMMC Details
What It Is
Cybersecurity Maturity Model Certification (CMMC) 2.0 is a U.S. Department of Defense (DoD) certification program ensuring cybersecurity protections for Federal Contract Information (FCI) and Controlled Unclassified Information (CUI) in the Defense Industrial Base (DIB). It employs a tiered, risk-based model with three cumulative levels drawn from FAR 52.204-21, NIST SP 800-171 Rev 2, and NIST SP 800-172.
Key Components
- Organized into 14 domains (e.g., Access Control, Incident Response, Risk Assessment)
- **Level 117 basic practices; **Level 2110 NIST controls; **Level 3+24 enhanced requirements
- Assessment scopes via enclaves; uses self-assessments, C3PAO, or DIBCAC verification
- POA&Ms allowed with strict 180-day closures; reported to SPRS or eMASS
Why Organizations Use It
- Mandatory for DoD contractors to secure contracts and avoid disqualification
- Mitigates supply chain risks, reduces breach costs, builds resilience
- Provides competitive bidding advantage and primes' preferred status
- Enhances stakeholder trust through verified maturity
Implementation Overview
- Phased approach: scoping, gap analysis, remediation, assessment preparation, sustainment
- Targets DIB primes/subcontractors of all sizes; flow-down required
- Typically 6-12 months; involves SSP development, evidence collection, triennial recertification
FDA 21 CFR Part 11 Details
What It Is
FDA 21 CFR Part 11 is a U.S. regulation setting criteria for electronic records and electronic signatures to be trustworthy, reliable, and equivalent to paper records and handwritten signatures. It governs computerized systems in FDA-regulated industries for predicate-rule-required records. The primary approach is control-based, with risk-based enforcement discretion outlined in the 2003 FDA guidance.
Key Components
- Subpart B: Controls for closed (§11.10) and open (§11.30) systems, including validation, audit trails, access limits, operational/authority/device checks, training, policies.
- Subpart C: Electronic signatures with uniqueness (§11.100), manifestation (§11.50), linking (§11.70), multi-component controls (§11.200/300).
- Built on principles of authenticity, integrity, confidentiality, non-repudiation. No formal certification; compliance via validation and documentation.
Why Organizations Use It
- Legally required when relying on electronic records/signatures for regulated activities.
- Mitigates enforcement risks, ensures data integrity, enables paperless operations.
- Drives efficiency, inspection readiness, stakeholder trust in life sciences.
Implementation Overview
- Risk-based: Scope records, classify systems, validate (IQ/OQ/PQ), deploy controls, train, change control.
- Applies to pharma, devices, biotech; any size; U.S.-centric with global relevance. (178 words)
Key Differences
| Aspect | CMMC | FDA 21 CFR Part 11 |
|---|---|---|
| Scope | Cybersecurity for FCI/CUI in DoD contracts | Electronic records/signatures trustworthiness |
| Industry | Defense Industrial Base contractors | Life sciences, pharma, medical devices |
| Nature | Mandatory DoD certification program | FDA regulation with enforcement discretion |
| Testing | Self-assess/C3PAO/DIBCAC every 3 years | Risk-based system validation (IQ/OQ/PQ) |
| Penalties | Contract ineligibility, debarment | Warning letters, product holds, fines |
Scope
Industry
Nature
Testing
Penalties
Frequently Asked Questions
Common questions about CMMC and FDA 21 CFR Part 11
CMMC FAQ
FDA 21 CFR Part 11 FAQ
You Might also be Interested in These Articles...
Unpacking the True Cost: A Guide to Calculating TCO for Modern Compliance Monitoring Software
Unpack the true Total Cost of Ownership (TCO) for compliance monitoring software. Factor in licenses, implementation, training, maintenance, and ROI savings for
Top 5 Reasons HITRUST CSF's MyCSF Platform Crushes Evidence Overload for R2 Assessments in Hybrid Cloud Environments
Explore top 5 advantages of HITRUST MyCSF for 1,400+ R2 controls in hybrid clouds. Slash docs by 30%, dodge under-scoping, achieve continuous compliance for hea
Your Compliance Command Center: How Modern Tools Orchestrate Cross-Departmental Adherence
Unlock your compliance command center with modern tools for real-time monitoring, automation & integrations across IT, HR, Legal & Finance. Slash non-compliance
Run Maturity Assessments with GRADUM
Transform your compliance journey with our AI-powered assessment platform
Assess your organization's maturity across multiple standards and regulations including ISO 27001, DORA, NIS2, NIST, GDPR, and hundreds more. Get actionable insights and track your progress with collaborative, AI-powered evaluations.
Explore More Comparisons
See how CMMC and FDA 21 CFR Part 11 compare against other standards